VAREX IMAGING (NASDAQ: VREX) and Vascular Solutions (NASDAQ:VASC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk.

Institutional and Insider Ownership

91.8% of VAREX IMAGING shares are owned by institutional investors. Comparatively, 80.2% of Vascular Solutions shares are owned by institutional investors. 6.9% of Vascular Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares VAREX IMAGING and Vascular Solutions’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
VAREX IMAGING $654.50 million 1.69 $115.80 million N/A N/A
Vascular Solutions N/A N/A N/A $0.70 80.00

VAREX IMAGING has higher revenue and earnings than Vascular Solutions.

Analyst Recommendations

This is a summary of recent ratings for VAREX IMAGING and Vascular Solutions, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VAREX IMAGING 0 1 1 0 2.50
Vascular Solutions 0 4 0 0 2.00

VAREX IMAGING presently has a consensus target price of $33.50, suggesting a potential upside of 14.10%. Vascular Solutions has a consensus target price of $55.50, suggesting a potential downside of 0.89%. Given VAREX IMAGING’s stronger consensus rating and higher probable upside, equities research analysts clearly believe VAREX IMAGING is more favorable than Vascular Solutions.


This table compares VAREX IMAGING and Vascular Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vascular Solutions 13.02% 15.78% 14.30%


VAREX IMAGING beats Vascular Solutions on 5 of the 9 factors compared between the two stocks.


Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect. The Medical business segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, radiation therapy and computer-aided detection. The Industrial business segment designs, manufactures, sells and services products for use in security and industrial inspection applications, such as cargo screening at ports and borders and non-destructive examination in a range of applications.

About Vascular Solutions

Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company’s product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Receive News & Stock Ratings for VAREX IMAGING Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VAREX IMAGING and related stocks with our FREE daily email newsletter.